- Published at
- by manilatimes.net
positive
positive
News for InnoCan Pharma Corporation (INNO.CN)
- Published at
- by benzinga.com
negativenegativeInnocan Pharma Corporation Closes Final Tranche Of Private Placement Unit Offering - InnoCan Pharma (OTC:INNPF)
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has closed the second and final tranche of its previously announced private placement offering of its units.- Published at
- by benzinga.com
positivepositiveCBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare - InnoCan Pharma (OTC:INNPF)
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has entered into an agreement with Research Capital Corporation as the sole agent and sole book-runner on a- Published at
- by marijuanastocks.com
positivepositiveInnocan Pharma Corporation (INNPF) Announces Brokered LIFE Offering of Units for Up to $3 Million
Innocan Pharma Announces Brokered LIFE Offering of Units for Up to $3…- Published at
- by prnewswire.com
positivepositiveInnocan Pharma Announces the Addition of Dr. Joseph V. Pergolizzi, Jr., M.D. to its Advisory Board
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pioneering pharmaceutical technology company...- Published at
- by investorideas.com
mixedmixedInvestor Ideas Potcasts, Cannabis News and Stocks on the Move: (OTC: PSYC), (OTCQB: DBCCF), (OTCQB: INNPF), (OTCQB: MEDIF) and (NASDAQ: CGC)
September 1, 2023 (Investorideas.com Newswire) investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potc...- Published at
- by prnewswire.com
neutralneutralInnocan Pharma Announces Clinical Study Results: Evidence of Reduced Osteoarthritis Pain in Dogs After Liposomal CBD Injection
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the results of a clinical...- Published at
- by prnewswire.com
positivepositiveInnocan Pharma Reports Q2 2023 Results Including US$2.706M Increase in Revenues Compared to Q2, 2022
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...- Published at
- by prnewswire.com
positivepositiveInnocan Pharma Announces Promising Successful Results in Efficacy Trial of Diabetic Foot Relief Treatment
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company specializing...- Published at
- by marijuanastocks.com
neutralneutralInnocan Pharma Corporation (INNPF) Announces Closing of Private Placement
Innocan Pharma Announces Closing of Private Placement Innocan Pharma Corporation (CSE: INNO)…- Published at
- by marketscreener.com
mixedmixedInnocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in Canada
Innocan Pharma Corporation is pleased to announce its been engaged into a manufacturing and distribution agreement dated August, 2021 with Ayurcann Inc. , a major Health Canada licensed producer... | August 11, 2021- Published at
- by financialpost.com
mixedmixedInnocan Pharma Corporation to Webcast Live at Life Sciences Investor Forum June 24th The Company invites investors, advisors and analysts, to attend its real-time, interactive presentations on LifeSci
HERZLIYA, Israel and CALGARY, Alberta, June 21, 2021 (GLOBE NEWSWIRE) — Innocan Pharma (OTC: INNPF) (CSE: INNO) (FSE: IP4) based in Israel, focused on…- Published at
- by marketscreener.com
mixedmixedInnocan Pharma Corporation to Webcast Live at Life Sciences Investor Forum June 24th
HERZLIYA, Israel and CALGARY, Alberta, June 21, 2021 -- Innocan Pharma based in Israel, focused on developing drug delivery platforms containing Cannabinoids today announced that...- Published at
- by investing.com
mixedmixed